On May 25, 2021, Thomas J. Russo, CFA, the Chief Financial Officer of Assembly Biosciences, Inc. (the “Company”), notified the Company of his decision to resign effective June 4, 2021 to pursue another opportunity. The Company is evaluating next steps with respect to the chief financial officer role.